converting between glp-1 agonists Switching GLP‐1 receptor in clinical practice: Expert consensus and practical guidance GLP-1 receptor agonists | How

doi: 10.1002/cphy.c130037 94 SedmanTHeinlaKVasarEVolkeV

[DOI] [PubMed] [Google Scholar] 58.Feng J., Zhang Z., Wallace M.B., Stafford J.A., Kaldor S.W., Kassel D.B., Navre M., Shi L., Skene R.J., Asakawa T., et al

doi: 10.1530/JOE-13-0221 28 PykeCHellerRSKirkRKrskovCReedtz-RungeSKaastrupPet al

Board-certified Dr

J., Zhang, X., Jaw-Tsai, S., Parkes, D

In contrast to previous studies, the incidence of bowel obstruction (including ileus, intussusception, volvulus, neurogenic bowel, megacolon, and other types of bowel obstruction) was not found to differ between SGLT-2 inhibitors and GLP-1RAs but tended to be nonsignificantly protective against these diagnoses (adjusted HR 0.83 [95% CI 0.69 to 1.01])